HDAC8, A Potential Therapeutic Target for the Treatment of Malignant Peripheral Nerve Sheath Tumors (MPNST)

• Gonzalo Lopez,

  Affiliation Comprehensive Cancer Center, The Ohio State University, Columbus, OH, United States of America

  ⨯
• Kate Lynn J. Bill,

  Affiliation Comprehensive Cancer Center, The Ohio State University, Columbus, OH, United States of America

  ⨯
• Hemant Kumar Bid,

  Affiliation Comprehensive Cancer Center, The Ohio State University, Columbus, OH, United States of America

  ⨯
• Danielle Braggio,

  Affiliation Comprehensive Cancer Center, The Ohio State University, Columbus, OH, United States of America

  ⨯
• Dylan Constantino,

  Affiliation Comprehensive Cancer Center, The Ohio State University, Columbus, OH, United States of America

  ⨯
• Bethany Prudner,

  Affiliation Comprehensive Cancer Center, The Ohio State University, Columbus, OH, United States of America

  ⨯
• Abeba Zewdu,

  Affiliation Comprehensive Cancer Center, The Ohio State University, Columbus, OH, United States of America

  ⨯
• Kara Batte,

  Affiliation Comprehensive Cancer Center, The Ohio State University, Columbus, OH, United States of America

  ⨯
• Dina Lev,

  Affiliation Surgery B, Sheba Medical Center, Tel Aviv, Israel

  ⨯
• Raphael E. Pollock

  * E-mail: raphael.pollock@osumc.edu

  Affiliation Surgical Oncology, The Ohio State University, Columbus, OH, United States of America

  ⨯